Frederick Beddingfield - Kythera Biopharmaceutica Insider

Kythera Biopharmaceuticals Inc -- USA Stock  

USD 0.11  0.00  0.00%

Chief Medical Officer

Dr. Frederick Beddingfield III M.D. Ph.D. is Chief Medical Officer of the Company. Dr. Beddingfield joined KYTHERA from Allergan Inc. a multispecialty health care company where he joined in 2003 and has served as Vice President and Global Therapeutic Area Head of Dermatology and Aesthetics at Allergan since August 2005 as well as Chief Medical Officer of Allergan Medical from December 2008 through August 2010. Since 2001 Dr. Beddingfield has also served as an Assistant Clinical Professor of Medicine Division of Dermatology at the David Geffen School of Medicine at UCLA
Age: 49  Executive Since 2013  Ph.D    
Beddingfield received his M.D. from the University of North Carolina at Chapel Hill, with honors, and a Bachelor of Arts in Psychology from North Carolina State University in Raleigh, N.C. In addition, Dr. Beddingfield holds a Ph.D. in Policy Analysis from the RAND Graduate School of Policy Studies.

Management Efficiency

The company has return on total asset (ROA) of (40.45) % which means that it has lost $40.45 on every $100 spent on asset. This is way below average.
The company currently holds 24.65 M in liabilities with Debt to Equity (D/E) ratio of 0.17 which may suggest the company is not taking enough advantage from borrowing. Kythera Biopharmaceuticals Inc has Current Ratio of 7.97 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

KYTHERA Biopharmaceuticals, Inc., a clinicalstage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription solutions for the aesthetic medicine market in the United States and internationally. Kythera Biopharmaceuticals Inc (KYTH) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 212 people. Kythera Biopharmaceutica is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Quick Import Now

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  NextLaunch Portfolio Quick Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Kythera Biopharmaceuticals Inc to your portfolio

Top Management

Kythera Biopharmaceutica Leadership Team
Nathaniel David, Director
Keith Klein, Executive
F Ball, Director
Douglas Rich, President, MBA
Heather Rowe, Executive
John Smither, CFO
Francois Kress, Director
Dennis Fenton, Director, Ph.D
Joseph Turner, Director, MBA
Camille Samuels, Director
Frederick Beddingfield, Executive, Ph.D
Elisabeth Sandoval, Executive, MBA
Hollings Renton, Director
Keith Leonard, CEO, MBA

Stock Performance

Kythera Biopharmaceutica Performance Indicators